Submitted:
29 October 2024
Posted:
29 October 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results



4. Discussion
| No | First author/Year/Reference | No. of patiens/Gender/Age | Medical history of aortic disease | Family history of aortic disease | Clinical features | Healthy pregnancy |
|---|---|---|---|---|---|---|
| 1. |
Hoffjan et al., 2011, [31] |
3 patients a.F,38 b.F,37 c.M, 41 |
a.Mild aortic dilation b.acute aortic dissection c. Thoracic aortic aneurysm |
a.1 brother-ascending aorta aneurysm and died at 46 years old; 1 brother and the father-thoracic aortic aneurysm b. 1 brother-died at 29 years old from acute aortic dissection c.no data available |
Not described |
a.2 healthy pregnancies b.2 healthy pregnancies c.- |
| 2. |
Keravnou et al., 2018, [35] |
1/M/30 | Type A aortic dissection | Father-aortic root and ascending aorta aneurysm (Bentall procedure performed) Mother-ascending aortic dilation |
Not described |
- |
| 3. | Marutani et al., 2023 [36] | 1/M/15 | Extensive dissection from the ascending aorta to the common iliac artery | Genetical tests not performed |
Not described |
- |
| 4. | Ware et al., 2014 [32] | 1/M/17 | Recurrent aortic dissection, severe aortic regurgitation | Twin brother- aortic dissection | Congenital mydriasis (both twins) |
- |
| 5. | Delsart et al., 2021 [37] | 1/F/29 | DeBakey type I aortic dissection | 2 siblings-acute aortic dissection Mother-died at 49 years old from type B aortic dissection |
Not described | No pregnancies |
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Goyal, A.; Keramati, A.R.; Czarny, M.J.; Resar, J.R.; Mani, A. The Genetics of Aortopathies in Clinical Cardiology. Clin. Med. Insights: Cardiol. 2017, 11. [Google Scholar] [CrossRef] [PubMed]
- Isselbacher, E.M.; Preventza, O.; Black, J.H.; Augoustides, J.G.; Beck, A.W.; Bolen, M.A.; Braverman, A.C.; Bray, B.E.; Brown-Zimmerman, M.M.; Chen, E.P.; et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 2022, 146, E334–E482. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Z.; Cecchi, A.C.; Prakash, S.K.; Milewicz, D.M. Risk Factors for Thoracic Aortic Dissection. Genes 2022, 13, 1814. [Google Scholar] [CrossRef] [PubMed]
- Ince, H.; A Nienaber, C. Etiology, pathogenesis and management of thoracic aortic aneurysm. Nat. Clin. Pr. Cardiovasc. Med. 2007, 4, 418–427. [Google Scholar] [CrossRef]
- Isselbacher, E.M.; Cardenas, C.L.L.; Lindsay, M.E. Hereditary Influence in Thoracic Aortic Aneurysm and Dissection. Circulation 2016, 133, 2516–2528. [Google Scholar] [CrossRef]
- Pinard, A.; Jones, G.T.; Milewicz, D.M. Genetics of Thoracic and Abdominal Aortic Diseases: Aneurysms, Dissections, and Ruptures. Circ. Res. 2019, 124, 588–606. [Google Scholar] [CrossRef]
- Renard, M.; Francis, C.; Ghosh, R.; Scott, A.F.; Witmer, P.D.; Adès, L.C.; Andelfinger, G.U.; Arnaud, P.; Boileau, C.; Callewaert, B.L.; et al. Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection. Circ. 2018, 72, 605–615. [Google Scholar] [CrossRef]
- Guo, D.-C.; Pannu, H.; Tran-Fadulu, V.; Papke, C.L.; Yu, R.K.; Avidan, N.; Bourgeois, S.; Estrera, A.L.; Safi, H.J.; Sparks, E.; et al. Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 2007, 39, 1488–1493. [Google Scholar] [CrossRef]
- Guo, D.-C.; Papke, C.L.; Tran-Fadulu, V.; Regalado, E.S.; Avidan, N.; Johnson, R.J.; Kim, D.H.; Pannu, H.; Willing, M.C.; Sparks, E.; et al. Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease. Am. J. Hum. Genet. 2009, 84, 617–627. [Google Scholar] [CrossRef]
- Roder, C.; Peters, V.; Kasuya, H.; Nishizawa, T.; Wakita, S.; Berg, D.; Schulte, C.; Khan, N.; Tatagiba, M.; Krischek, B. Analysis of ACTA2 in European Moyamoya disease patients. Eur. J. Paediatr. Neurol. 2011, 15, 117–122. [Google Scholar] [CrossRef]
- Dragan, A.L.; Voth, D.E. Coxiella burnetii: international pathogen of mystery. Microbes Infect. 2019, 22, 100–110. [Google Scholar] [CrossRef] [PubMed]
- Neupane K, Kaswan D. Coxiella burnetii Infection. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Oct 22]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK557893/.
- Madariaga, M.G.; Rezai, K.; Trenholme, G.M.; A Weinstein, R. Q fever: a biological weapon in your backyard. Lancet Infect. Dis. 2003, 3, 709–721. [Google Scholar] [CrossRef] [PubMed]
- Oyston, P.C.F.; Davies, C. Q fever: the neglected biothreat agent. J. Med Microbiol. 2011, 60, 9–21. [Google Scholar] [CrossRef] [PubMed]
- Cherry, C.C.; Nichols Heitman, K.; Bestul, N.C.; Kersh, G.J. Acute and chronic Q fever national surveillance – United States, 2008–2017. Zoonoses Public Health 2022, 69, 73–82. [Google Scholar] [CrossRef]
- España, P.P.; Uranga, A.; Cillóniz, C.; Torres, A. Q Fever (Coxiella Burnetii). Semin. Respir. Crit. Care Med. 2020, 41, 509–521. [Google Scholar] [CrossRef]
- Chiu, C.K.; Durrheim, D.N. A review of the efficacy of human Q fever vaccine registered in Australia. New South Wales Public Heal. Bull. 2007, 18, 133–6. [Google Scholar] [CrossRef]
- Raoult, D.; Tissot-Dupont, H.; Foucault, C.; Gouvernet, J.; Fournier, P.E.; Bernit, E.; Stein, A.; Nesri, M.; Harle, J.R.; Weiller, P.J. Q Fever 1985-1998: Clinical and Epidemiologic Features of 1,383 Infections. Medicine 2000, 79, 109–123. [Google Scholar] [CrossRef]
- Kofteridis, D.P.; Mazokopakis, E.E.; Tselentis, Y.; Gikas, A. Neurological complications of acute Q fever infection. Eur. J. Epidemiology 2004, 19, 1051–1054. [Google Scholar] [CrossRef]
- Million, M.; Lepidi, H.; Raoult DFièvre, Q. actualités diagnostiques et thérapeutiques. Médecine Mal Infect. 2009, 39, 82–94. [Google Scholar] [CrossRef]
- Raoult, D.; Houpikian, P.; Dupont, H.T.; Riss, J.M.; Arditi-Djiane, J.; Brouqui, P. Treatment of Q Fever Endocarditis: Comparison of 2 Regimens Containing Doxycycline and Ofloxacin or Hydroxychloroquine. Arch Intern Med. 1999, 159, 167. [Google Scholar] [CrossRef]
- Delgado, V.; Marsan, N.A.; de Waha, S.; Bonaros, N.; Brida, M.; Burri, H.; Caselli, S.; Doenst, T.; Ederhy, S.; Erba, P.A.; et al. Correction to: 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). Eur. Hear. J. 2023, 45, 56–56. [Google Scholar] [CrossRef]
- Cozma, D.; Streian, C.G.; Vacarescu, C.; Mornos, C. Back to sinus rhythm from atrial flutter or fibrillation: dabigatran is safe without transoesophageal control. Kardiologia Polska 2016, 74, 425–430. [Google Scholar] [CrossRef] [PubMed]
- Arnautu, S.F.; Arnautu, D.A.; Lascu, A.; Hajevschi, A.A.; Rosca, C.I.I.; Sharma, A.; Jianu, D.C. A Review of the Role of Transthoracic and Transesophageal Echocardiography, Computed Tomography, and Magnetic Resonance Imaging in Cardioembolic Stroke. Med Sci. Monit. 2022, 28, e936365–1. [Google Scholar] [CrossRef]
- Richards, S.; Aziz, N.; Bale, S.; Bick, D.; Das, S.; Gastier-Foster, J.; Grody, W.W.; Hegde, M.; Lyon, E.; Spector, E.; et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015, 17, 405–424. [Google Scholar] [CrossRef]
- Roder, C.; Nayak, N.R.; Khan, N.; Tatagiba, M.; Inoue, I.; Krischek, B. Genetics of Moyamoya disease. J. Hum. Genet. 2010, 55, 711–716. [Google Scholar] [CrossRef]
- Bozza, S.; Graziani, A.; Borghi, M.; Marini, D.; Duranti, M.; Camilloni, B. Case report: Coxiella burnetii endocarditis in the absence of evident exposure. Front. Med. 2023, 10, 1220205. [Google Scholar] [CrossRef]
- Deyell, M.W.; Chiu, B.; Ross, D.B.; Alvarez, N. Q fever endocarditis: A case report and review of the literature. Can. J. Cardiol. 2006, 22, 781–785. [Google Scholar] [CrossRef]
- Afrasiabian, S.; Esmaeili, S.; Hajibagheri, K.; Hadizadeh, N.; Lotfi, G.; Veysi, A. Endocarditis Caused by Coxiella burnetii: A Case Report in Western Iran. J. Arthropod-Borne Dis. 2024, 18, 78–83. [Google Scholar] [CrossRef]
- Krol, V.; Kogan, V.; Cunha, B.A. Q fever bioprosthetic aortic valve endocarditis (PVE) successfully treated with doxycycline monotherapy. Hear. Lung 2008, 37, 157–160. [Google Scholar] [CrossRef]
- Hoffjan, S.; Waldmüller, S.; Blankenfeldt, W.; Kötting, J.; Gehle, P.; Binner, P.; Epplen, J.T.; Scheffold, T. Three novel mutations in the ACTA2 gene in German patients with thoracic aortic aneurysms and dissections. Eur. J. Hum. Genet. 2011, 19, 520–524. [Google Scholar] [CrossRef]
- Ware, S.M.; Shikany, A.; Landis, B.J.; James, J.F.; Hinton, R.B. Twins With Progressive Thoracic Aortic Aneurysm, Recurrent Dissection and ACTA2 Mutation. Pediatrics 2014, 134, e1218–e1223. [Google Scholar] [CrossRef] [PubMed]
- Coulon, C. Thoracic aortic aneurysms and pregnancy. Presse Médicale 2015, 44, 1126–1135. [Google Scholar] [CrossRef] [PubMed]
- Braverman, A.C.; Mittauer, E.; Harris, K.M.; Evangelista, A.; Pyeritz, R.E.; Brinster, D.; Conklin, L.; Suzuki, T.; Fanola, C.; Ouzounian, M.; et al. Clinical Features and Outcomes of Pregnancy-Related Acute Aortic Dissection. JAMA Cardiol. 2021, 6, 58–66. [Google Scholar] [CrossRef] [PubMed]
- Keravnou, A.; Bashiardes, E.; Michailidou, K.; Soteriou, M.; Moushi, A.; Cariolou, M. Novel variants in the ACTA2 and MYH11 genes in a Cypriot family with thoracic aortic aneurysms: a case report. BMC Med Genet. 2018, 19, 208. [Google Scholar] [CrossRef]
- Marutani, S.; Nishino, T.; Shimokawa, O.; Pooh, R.K.; Morisaki, H.; Inamura, N. Aortic Dissection and a Previously Unreported ACTA2 Missense Variant Mutation in a Young Patient: A Case Report. Pediatr. Dev. Pathol. 2023, 26, 494–498. [Google Scholar] [CrossRef]
- Delsart, P.; Vanlerberghe, C.; Juthier, F.; Sobocinski, J.; Domanski, O.; Longere, B.; Hanna, N.; Arnaud, P.; Marsili, L. The natural history of a family with aortic dissection associated with a novel ACTA2 variant. Ann. Vasc. Surg. 2021, 77, 348–e7. [Google Scholar] [CrossRef]
| Serology | Value |
|---|---|
| IgG phase I antibodies | |
| >1:4096 | |
| IgM phase I antibodies | |
| 1:2024 | |
| IgG phase II antibodies | |
| >1:4096 | |
| IgM phase II antibodies | |
| 1:1024 |
| No | First author/Year/Reference | No. of patiens/Gender/Age | History of cardiovascular surgery | Fever history | Surgical or medical treatment |
|---|---|---|---|---|---|
| 1 | Bozza et al, 2023[27] | 1/M/55 | Aortic valve replacement (aortic regurgitation and aneurysm) | 1 month | Medical: doxycycline (100 mg/bid) and hydroxychloroquine (200 mg/tid |
| 2 | Deyell et al, 2006 [28] | 1/M/31 | Open valvulotomy for congenital aortic stenosis + mechanical aortic replacement for severe aortic regurgitation | Not described | Surgical: Aortic root replacement of the ascending aorta and aortic valve replacement |
| 3 | Afrasiabian et al, 2024 [29] | 1/F/67 | Aortic valve replacement | 1 month | Medical (Levofloxacin-intolerance of doxycycline) |
| 4 | Krol et al, 2008 [30] | 1/F/43 | Aortic valve replacement (bicuspid aortic valve) | Fever history, but no time described | Both: Medical (doxycycline monotherapy) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).